Dr. Seth Kalichman
University of Connecticut
Department of Psychology

Professor Kalichman dedicates his research to preventing the spread of HIV/AIDS and caring for those affected by the HIV epidemic. His research is focused in the southern United States and South Africa.

Read more

His work has been continuously and exclusively funded by the National Institutes of Health since 1992. He was previously on the faculties of Loyola University of Chicago, Georgia State University, and the Medical College of Wisconsin where he worked under the direction of Jeffrey A. Kelly to help establish the Center for AIDS Intervention Research (CAIR).

He is currently the director of the Southeast HIV and AIDS Research and Evaluation (SHARE) Project, a research program within the AIDS Survival Project in Atlanta, Georgia. His research in South Africa is in collaboration with the Human Sciences Research Council.

Professor Kalichman serves on NIH grant review panels, has over 200 peer-reviewed journal articles, and has authored and edited five books in the area of HIV/AIDS prevention and care services, including Positive Prevention, recently published by Springer. He is also the current editor of the bimonthly journal AIDS and Behavior. Professor Kalichman was the recipient of the 1997 Early Career Award in Health Psychology from the American Psychological Association and the 2005 Distinguished Scientist Award from the Society for Behavioral Medicine.

Dr. David Margolis
University of North Carolina at Chapel Hill

Dr. David Margolis is professor of Medicine, Microbiology, Immunology and Epidemiology at the University of North Carolina at Chapel Hill. He also serves as Director of the UNC HIV Cure Center.

Read more

A molecular virologist and clinical investigator, he received a bachelor’s degree in Biology from Harvard and a degree in Medicine from Tufts University.

Dr. Margolis’ laboratory studies the interaction of HIV with its host, aiming to translate the discoveries in molecular biology and virology to the clinic to aid in the treatment of HIV infection.

As the leader of the Collaboratory of AIDS Researchers for Eradication (CARE), Dr. Margolis aims to pursue a comprehensive collaborative search for approaches to eradicate HIV. He currently leads a large partnership of HIV researchers working to force HIV out of “latency” in order to attempt to kill virus particles that typically lie dormant and hidden from therapy.

In addition, Dr. Margolis is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the American Society of Clinical Investigation, and an editorial board member of the Journal of Virology of the ASM, and the Journal of Infectious Diseases of the IDSA.

Dr. Caroline Sabin
University College London

Caroline Sabin is Professor of Medical Statistics and Epidemiology in the Research Department of Infection and Population Health at University College London. She obtained her PhD in Epidemiology and Medical Statistics from the University of London.

Read more

Professor Sabin initiated and is one of the Principal Investigators of the UK Collaborative HIV Cohort (UK CHIC) study, a major multicenter study of more than 50,000 people living with HIV in the UK, one of the largest clinical cohorts of people living with HIV worldwide.

Additionally, Professor Sabin works as the principal statistician for the Data collection on Adverse events of anti-HIV Drugs (D:A:D) study, a large international multi-cohort study, which aims to describe the relationship between antiretroviral drugs and cardiovascular disease. She is the co-PI on the POPPY study with Dr Alan Winston, a new UK cohort that aims to describe the clinical and psychological outcomes of the ageing HIV population and the healthcare resources that are used by this population, and is an investigator on the EU-funded COBRA study of co-morbidities in UK and Dutch people living with HIV (with Professor Peter Reiss). She is also a member of the Scientific Oversight Workpackage for the EuroCoord collaboration, a major EU-funded network that involves the majority of cohorts of people living with HIV in Europe.

Her research interests focus on: describing the natural history of infection and identifying prognostic markers for disease progression, describing the response to antiretroviral therapy, and describing the frequency of and factors associated with adverse events of antiretroviral therapy. She is currently working on studies that will investigate the new issues that face the population of people living with HIV as they age, including comorbidities and possible neurocognitive impairment.

Dr. Veronica Miller
UC Berkeley School of Public Health

Veronica Miller is the executive director of the Forum for Collaborative HIV Research (The Forum) and a Senior Researcher and Lecturer at the UC Berkeley School of Public Health.

Read more

Dr. Miller obtained a Bachelor of Science in Microbiology and a Doctor of Philosophy in Immunology from the University of Manitoba.
A leading expert resolving significant health policy and public health issues, Dr. Miller has extensive experience working with major global and US organizations and agencies involved in HIV, HCV, and fatty liver disease research and regulatory policy. Some of her efforts to advance public health policy include the National Summit program, focusing on the implementation of the National HIV/AIDS Strategy, the Viral Hepatitis Action Plan and the Bay Area Health Disparities Program.

Dr. Miller was co-founder and chair of the EuroGuidelines Group on HIV Drug Resistance established with the purpose of assuring a common standard of care for patients in all European states. She has also been an active member of several collaborative projects, including the EuroSIDA study. She has published over 90 peer-reviewed publications on HIV treatment outcomes and regulatory strategies for HIV and HCV.

Dr. Roy (Trip) Gulick
Weill Cornell Medical College

Dr. Roy (Trip) Gulick is Gladys and Roland Harriman Professor of Medicine and Chief of the Division of Infectious Diseases at Weill Medical College of Cornell University, as well as an attending physician at New York Presbyterian Hospital.

Read more

Dr. Gulick received his undergraduate education at John Hopkins University, earned his MD degree at Columbia University College of Physicians and Surgeons, and his Master of Public Health from Harvard University, focusing on clinical trial design. He currently serves as the Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the National Institutes of Health-funded AIDS Clinical Trials Group (ACTG).

As an internationally recognized leader in clinical HIV research, Dr. Gulick led one of the first studies of three-drug combination antiretroviral therapy, which ultimately redefined the standard-of-care for HIV treatment and lead to significant declines in HIV-related morbidity and mortality.

Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention, and assess antiretroviral agents with new mechanisms of action. He also serves as a board member of the International Antiviral Society-USA, and as co-chairman of the Panel on Clinical Practices for Treatment of HIV Infection of the U.S. Department of Health and Human Services.

Latest News


| Uncategorized | No Comments

« Avec notre étude, nous tenterons de vérifier si un médicament breveté et d’usage courant peut donner lieu à une…

Publication des Lignes directrices canadiennes sur la PPrE et la PPE

| Uncategorized | No Comments

Après environ deux années de travail et de consultation, les premières lignes directrices canadiennes sur la prophylaxie pré-exposition (PPrE) et…

Dr Mark Wainberg

| Uncategorized | No Comments

Le personnel et la direction du Réseau offrent leurs sincères condoléances à l’occasion du décès du Dr Mark Wainberg. Mark…

Postdoctorat en vedette : Dr Malika Sharma

| Uncategorized | No Comments

Les taux de VIH au Canada continuent d’augmenter malgré les nouveaux outils à notre portée pour prévenir les nouvelles infections….